Organization Profile

You just read:

Aeterna Zentaris Announces Initiation of Phase 2 Portion of Phase 1/2 Trial with AEZS-108 in Prostate Cancer

News provided by

AETERNA ZENTARIS INC.

Nov 12, 2012, 07:30 ET